| Susan L Peluchiwski, CRNA | |
|
1555 Barrington Rd, Hoffman Estates, IL 60169-1019 | |
| (847) 490-2923 | |
| Not Available |
| Full Name | Susan L Peluchiwski |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 29 Years |
| Location | 1555 Barrington Rd, Hoffman Estates, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437158086 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 041323445 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Alexius Medical Center | Hoffman estates, IL | Hospital |
| Javon Bea Hospital | Rockford, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rockford Health Physicians | 2567374036 | 289 |
| Midwest Anesthesia Partners Llc | 6204737596 | 189 |
| Premiere Anesthesia Group Llc | 6608187810 | 8 |
| Chicago Pain Relief Pc | 8820354897 | 2 |
News Archive
Combining nature and Greek mythology, researchers at the Technion-Israel Institute of Technology have developed a tiny "Trojan Horse" system for delivering cancer-fighting drugs. With this system, the drugs are delivered only once they are inside the cancerous cells, so there is no damage to the healthy cells in the surrounding area.
Research from Guangzhou, China shows that a high proportion of children with myopia do not have highly myopic parents, indicating that environmental as well as genetic factors contribute to the development of the eye condition.
Children could have their cholesterol levels tested at about 15 months of age to prevent heart disease later in life, say doctors in a study published on bmj.com today.
The Wall Street Journal: "State governments expect tax collections to grow for the first time in two years as tax increases and a recovering economy lead to higher collections. But states are still likely to face at least two more years of financial troubles and about half will see gaps in this year's budgets if Congress doesn't extend special Medicaid payments that were part of the 2009 stimulus act, according to a report expected to be released Tuesday by the National Conference of State Legislatures.
OncoGenex Pharmaceuticals Inc. today announced that it concluded a meeting with the U.S. Food and Drug Administration (FDA) on October 7, 2008, and that the FDA agreed that "durable pain palliation is an acceptable and desirable study endpoint" to support a product marketing approval for OGX-011 as a treatment for hormone refractory prostate cancer (HRPC).
› Verified 8 days ago
| Entity Name | Rockford Health Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043242886 PECOS PAC ID: 2567374036 Enrollment ID: O20031103000584 |
News Archive
Combining nature and Greek mythology, researchers at the Technion-Israel Institute of Technology have developed a tiny "Trojan Horse" system for delivering cancer-fighting drugs. With this system, the drugs are delivered only once they are inside the cancerous cells, so there is no damage to the healthy cells in the surrounding area.
Research from Guangzhou, China shows that a high proportion of children with myopia do not have highly myopic parents, indicating that environmental as well as genetic factors contribute to the development of the eye condition.
Children could have their cholesterol levels tested at about 15 months of age to prevent heart disease later in life, say doctors in a study published on bmj.com today.
The Wall Street Journal: "State governments expect tax collections to grow for the first time in two years as tax increases and a recovering economy lead to higher collections. But states are still likely to face at least two more years of financial troubles and about half will see gaps in this year's budgets if Congress doesn't extend special Medicaid payments that were part of the 2009 stimulus act, according to a report expected to be released Tuesday by the National Conference of State Legislatures.
OncoGenex Pharmaceuticals Inc. today announced that it concluded a meeting with the U.S. Food and Drug Administration (FDA) on October 7, 2008, and that the FDA agreed that "durable pain palliation is an acceptable and desirable study endpoint" to support a product marketing approval for OGX-011 as a treatment for hormone refractory prostate cancer (HRPC).
› Verified 8 days ago
| Entity Name | Midwest Anesthesia Partners Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255380184 PECOS PAC ID: 6204737596 Enrollment ID: O20040120000034 |
News Archive
Combining nature and Greek mythology, researchers at the Technion-Israel Institute of Technology have developed a tiny "Trojan Horse" system for delivering cancer-fighting drugs. With this system, the drugs are delivered only once they are inside the cancerous cells, so there is no damage to the healthy cells in the surrounding area.
Research from Guangzhou, China shows that a high proportion of children with myopia do not have highly myopic parents, indicating that environmental as well as genetic factors contribute to the development of the eye condition.
Children could have their cholesterol levels tested at about 15 months of age to prevent heart disease later in life, say doctors in a study published on bmj.com today.
The Wall Street Journal: "State governments expect tax collections to grow for the first time in two years as tax increases and a recovering economy lead to higher collections. But states are still likely to face at least two more years of financial troubles and about half will see gaps in this year's budgets if Congress doesn't extend special Medicaid payments that were part of the 2009 stimulus act, according to a report expected to be released Tuesday by the National Conference of State Legislatures.
OncoGenex Pharmaceuticals Inc. today announced that it concluded a meeting with the U.S. Food and Drug Administration (FDA) on October 7, 2008, and that the FDA agreed that "durable pain palliation is an acceptable and desirable study endpoint" to support a product marketing approval for OGX-011 as a treatment for hormone refractory prostate cancer (HRPC).
› Verified 8 days ago
| Entity Name | Premiere Anesthesia Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720467392 PECOS PAC ID: 6608187810 Enrollment ID: O20150615001464 |
News Archive
Combining nature and Greek mythology, researchers at the Technion-Israel Institute of Technology have developed a tiny "Trojan Horse" system for delivering cancer-fighting drugs. With this system, the drugs are delivered only once they are inside the cancerous cells, so there is no damage to the healthy cells in the surrounding area.
Research from Guangzhou, China shows that a high proportion of children with myopia do not have highly myopic parents, indicating that environmental as well as genetic factors contribute to the development of the eye condition.
Children could have their cholesterol levels tested at about 15 months of age to prevent heart disease later in life, say doctors in a study published on bmj.com today.
The Wall Street Journal: "State governments expect tax collections to grow for the first time in two years as tax increases and a recovering economy lead to higher collections. But states are still likely to face at least two more years of financial troubles and about half will see gaps in this year's budgets if Congress doesn't extend special Medicaid payments that were part of the 2009 stimulus act, according to a report expected to be released Tuesday by the National Conference of State Legislatures.
OncoGenex Pharmaceuticals Inc. today announced that it concluded a meeting with the U.S. Food and Drug Administration (FDA) on October 7, 2008, and that the FDA agreed that "durable pain palliation is an acceptable and desirable study endpoint" to support a product marketing approval for OGX-011 as a treatment for hormone refractory prostate cancer (HRPC).
› Verified 8 days ago
| Entity Name | Chicago Pain Relief Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356852735 PECOS PAC ID: 8820354897 Enrollment ID: O20171107002306 |
News Archive
Combining nature and Greek mythology, researchers at the Technion-Israel Institute of Technology have developed a tiny "Trojan Horse" system for delivering cancer-fighting drugs. With this system, the drugs are delivered only once they are inside the cancerous cells, so there is no damage to the healthy cells in the surrounding area.
Research from Guangzhou, China shows that a high proportion of children with myopia do not have highly myopic parents, indicating that environmental as well as genetic factors contribute to the development of the eye condition.
Children could have their cholesterol levels tested at about 15 months of age to prevent heart disease later in life, say doctors in a study published on bmj.com today.
The Wall Street Journal: "State governments expect tax collections to grow for the first time in two years as tax increases and a recovering economy lead to higher collections. But states are still likely to face at least two more years of financial troubles and about half will see gaps in this year's budgets if Congress doesn't extend special Medicaid payments that were part of the 2009 stimulus act, according to a report expected to be released Tuesday by the National Conference of State Legislatures.
OncoGenex Pharmaceuticals Inc. today announced that it concluded a meeting with the U.S. Food and Drug Administration (FDA) on October 7, 2008, and that the FDA agreed that "durable pain palliation is an acceptable and desirable study endpoint" to support a product marketing approval for OGX-011 as a treatment for hormone refractory prostate cancer (HRPC).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Susan L Peluchiwski, CRNA 2413 W Algonquin Rd # 608, Algonquin, IL 60102-9402 Ph: (224) 333-0033 | Susan L Peluchiwski, CRNA 1555 Barrington Rd, Hoffman Estates, IL 60169-1019 Ph: (847) 490-2923 |
News Archive
Combining nature and Greek mythology, researchers at the Technion-Israel Institute of Technology have developed a tiny "Trojan Horse" system for delivering cancer-fighting drugs. With this system, the drugs are delivered only once they are inside the cancerous cells, so there is no damage to the healthy cells in the surrounding area.
Research from Guangzhou, China shows that a high proportion of children with myopia do not have highly myopic parents, indicating that environmental as well as genetic factors contribute to the development of the eye condition.
Children could have their cholesterol levels tested at about 15 months of age to prevent heart disease later in life, say doctors in a study published on bmj.com today.
The Wall Street Journal: "State governments expect tax collections to grow for the first time in two years as tax increases and a recovering economy lead to higher collections. But states are still likely to face at least two more years of financial troubles and about half will see gaps in this year's budgets if Congress doesn't extend special Medicaid payments that were part of the 2009 stimulus act, according to a report expected to be released Tuesday by the National Conference of State Legislatures.
OncoGenex Pharmaceuticals Inc. today announced that it concluded a meeting with the U.S. Food and Drug Administration (FDA) on October 7, 2008, and that the FDA agreed that "durable pain palliation is an acceptable and desirable study endpoint" to support a product marketing approval for OGX-011 as a treatment for hormone refractory prostate cancer (HRPC).
› Verified 8 days ago
Jane M. Vodvarka, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1555 Barrington Rd, Hoffman Estates, IL 60169 Phone: 847-490-2923 | |
Nathan E. Kimes, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1555 N. Barrington Road, Hoffman Estates, IL 60169 Phone: 847-490-2923 | |
Ms. Michelle C. Brown, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1555 Barrington Rd, Hoffman Estates, IL 60169 Phone: 847-490-6932 Fax: 847-884-3677 | |
Dimitri Bagrov, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1555 Barrington Rd, #1400, Hoffman Estates, IL 60169 Phone: 847-836-7015 | |
Ms. Ann M. Briggs, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1555 Barrington Rd, Hoffman Estates, IL 60169 Phone: 847-490-2923 | |
Margaret S. Chapala, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1555 Barrington Rd, Hoffman Estates, IL 60169 Phone: 847-490-2923 | |
Beverly Reich, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1555 Barrington Rd, Hoffman Estates, IL 60169 Phone: 847-490-2923 |